Xtant Medical/XTNT

$0.84

1.2%
-
1D1W1MYTD1YMAX

About Xtant Medical

Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical Products, Thoracolumbar Products, Sacroiliac Joint Products, Interbody Products and Interlaminar Stabilization Products.

Ticker

XTNT

Sector

Healthcare

Trading on

AMEX

Industry

Medical Equipment & Supplies

CEO

Sean Browne

Employees

207

Headquarters

Belgrade, United States

Xtant Medical Metrics

BasicAdvanced
$108.08M
Market cap
-
P/E ratio
-$0.00
EPS
0.33
Beta
-
Dividend rate
$108.08M
0.33477
$1.45
$0.60
153.96K
2.822
1.217
33.658
42.786
52.285
-4.02%
0.86%
1.54%
1.15%
1.184
2.104
3.182
57.5%
95.37%
19.62%

What the Analysts think about Xtant Medical

Analyst Ratings

Majority rating from 2 analysts.
Buy

Price Targets

Average projection from 2 analysts.
129.76% upside
High $2.00
Low $1.85
$0.84
Current price
$1.93
Average price target

Xtant Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-15.3% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$28.1M
12.4%
Net income
$-4.3M
-146.74%
Profit margin
-15.3%
-141.58%

Xtant Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 20%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.02
-$0.02
$0.07
-$0.03
-
Expected
-$0.03
-$0.02
-$0.02
-$0.03
-$0.02
Surprise
-33.33%
0%
-450%
20%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Xtant Medical stock?

Xtant Medical (XTNT) has a market cap of $108.08M as of April 23, 2024.

What is the P/E ratio for Xtant Medical stock?

The price to earnings (P/E) ratio for Xtant Medical (XTNT) stock is 0 as of April 23, 2024.

Does Xtant Medical stock pay dividends?

No, Xtant Medical (XTNT) stock does not pay dividends to its shareholders as of April 23, 2024.

When is the next Xtant Medical dividend payment date?

Xtant Medical (XTNT) stock does not pay dividends to its shareholders.

What is the beta indicator for Xtant Medical?

Xtant Medical (XTNT) has a beta rating of 0.33. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

What is the Xtant Medical stock price target?

The target price for Xtant Medical (XTNT) stock is $1.93, which is 129.76% above the current price of $0.84. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Xtant Medical stock

Buy or sell Xtant Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing